1999

Bücher und Buchbeiträge

H. Auterhoff, J. Knabe und H.-D. Höltje.
Lehrbuch der Pharmazeutischen Chemie, 14. Auflage.
Wissenschaftliche Verlagsgesellschaft mbH Stuttgart (1999)

Originalarbeiten

H. Lemoine, H. Weber, A. Derix, U. Uhrig, R. Mannhold, H.-D. Höltje
6-varied benzopyrans: vasorelexant activity in rat aorta and trachea, structure activity relationship, conversion to muscarinic antagonists
European Journal of Pharmacology 378, 85-97 (1999)

A. Gysler, B. Kleuser, W. Sippl, K. Lange, H.C. Korting, H.-D. Höltje, M. Schäfer-Korting
Differential Skin Penetration and Metabolism of Topical Glucocorticoids contributes to the Increased Benefit/Risk Ratio of Prednicarbate
Pharm. Res. 16, 1386-1391 (1999)

Abstracts

R. Ghosh, W. Sippl, H. Stark and H.-D. Höltje.
Molecular Modelling and 3D-QSAR Studies of Dopamine D3-Receptor
Antagonists 12th Camerino Noordwijkerhout Symposium Perspectives in Receptor Research,
Camerino/Italien,
5.-9.9.1999.
Abstract-Book S. 116

Holz A., Gurrath M., Hoeltje H.D.
Pharmacophore Model of Non-Peptide Bradykinin B2-Receptor Antagonists
DoktorandInnentagung 1999 Freiburg i.Br.
11.-13.03.1999
Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 1, 35, (1999)

S. Buchwald-Werner and H.-D. Höltje
Computational Study on the Importance of pi-pi Interaction for Chiral Discrimination
DoktorandInnentagung 1999 Freiburg i.Br.
11.-13.03.1999
Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 1, 30, (1999)

S. Bendels and H.-D. Höltje
Three-dimensional Model of the sodium channel-specific neurotoxin Lqq V
DoktorandInnentagung 1999 Freiburg i.Br.
11.-13.03.1999
Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 1, 29, (1999)

W. Sippl, J.M. Contreras, Y. Rival and C.G. Wermuth
Struktur-basierte 3D QSAR Analyse neuer Acetylcholinesterase Inhibitoren
Jahrestagung der Östereichischen Pharmazeutischen Gesellschaft (ÖPhG 1999)
Innsbruck, 1.10.1999